金斯瑞生物(1548.HK)逆势上涨,盘中一度涨超10%,报12.08港元,股价创4月3日以来新高。 消息面上,金斯瑞生物与涛烜科学达成战略合作,结合单B细胞高通量筛选技术与金斯瑞的抗体开发服务平台,推出“端到端”抗体发现解决方案,以缩短研发周期、降低成本,提升全球生物医药企业研发效率。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.